alpha labs retatrutide 10mg Retatrutide 10mg Triple Agonist |

Retatrutide: The Triple-Agonist Retatrutide (LY3437943) is a novel triple-receptor agonist developed by Eli Lilly that simultaneously targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors

They dont need progressively higher doses to maintain effect (maintenance doses are actually lower than weight loss doses)

Le dtail complet (ligibilit, prix par dose, reste charge, parcours) est dans notre guide sur le remboursement de Wegovy et Mounjaro

Remember, everyone is different, so its worth talking with your provider about which option fits best with your needs, goals, and budget